|
1
|
Pastor JC: Proliferative
vitreoretinopathy: an overview. Surv Ophthalmol. 43:3–18. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weller M, Wiedemann P and Heimann K:
Proliferative vitreoretinopathy - is it anything more than wound
healing at the wrong place? Int Ophthalmol. 14:105–117. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Girard P, Mimoun G, Karpouzas I and
Montefiore G: Clinical risk factors for proliferative
vitreoretinopathy after retinal detachment surgery. Retina.
14:417–424. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pastor JC, de la Rúa ER and Martín F:
Proliferative vitreoretinopathy: risk factors and pathobiology.
Prog Retin Eye Res. 21:127–144. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ryan SJ: The pathophysiology of
proliferative vitreoretinopathy in its management. Am J Ophthalmol.
100:188–193. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wiedemann P and Weller M: The
pathophysiology of proliferative vitreoretinopathy. Acta Ophthalmol
Suppl. 189:3–15. 1988.
|
|
7
|
Baudouin C, Hofman P, Brignole F, Bayle J,
Loubière R and Gastaud P: Immunocytology of cellular components in
vitreous and subretinal fluid from patients with proliferative
vitreoretinopathy. Ophthalmologica. 203:38–46. 1991. View Article : Google Scholar
|
|
8
|
Vinores SA, Campochiaro PA and Conway BP:
Ultrastructural and electron-immunocytochemical characterization of
cells in epiretinal membranes. Invest Ophthalmol Vis Sci. 31:14–28.
1990.PubMed/NCBI
|
|
9
|
Wong CA, Potter MJ, Cui JZ, et al:
Induction of proliferative vitreoretinopathy by a unique line of
human retinal pigment epithelial cells. Can J Ophthalmol.
37:211–220. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang CH, Huang TF, Liu KR, Chen MS and
Hung PT: Inhibition of retinal pigment epithelial cell-induced
tractional retinal detachment by disintegrins, a group of
Arg-Gly-Asp-containing peptides from viper venom. Invest Ophthalmol
Vis Sci. 37:843–854. 1996.PubMed/NCBI
|
|
11
|
Mukherjee S and Guidry C: The insulin-like
growth factor system modulates retinal pigment epithelial cell
tractional force generation. Invest Ophthalmol Vis Sci.
48:1892–1899. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Spraul CW, Kaven C, Amann J, Lang GK and
Lang GE: Effect of insulin-like growth factors 1 and 2, and glucose
on the migration and proliferation of bovine retinal pigment
epithelial cells in vitro. Ophthalmic Res. 32:244–248. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mitsuhiro MR, Eguchi S and Yamashita H:
Regulation mechanisms of retinal pigment epithelial cell migration
by the TGF-beta superfamily. Acta Ophthalmol Scand. 81:630–638.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Spraul CW, Kaven C, Lang GK and Lang GE:
Effect of growth factors on bovine retinal pigment epithelial cell
migration and proliferation. Ophthalmic Res. 36:166–171. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hollborn M, Bringmann A, Faude F,
Wiedemann P and Kohen L: Signaling pathways involved in PDGF-evoked
cellular responses in human RPE cells. Biochem Biophys Res Commun.
344:912–919. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu J, Liu F, Cui SJ, et al: Vitreous
proteomic analysis of proliferative vitreoretinopathy. Proteomics.
8:3667–3678. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng XZ, Du LF and Wang HP: An
immunohistochemical analysis of a rat model of proliferative
vitreoretinopathy and a comparison of the expression of TGF-β and
PDGF among the induction methods. Bosn J Basic Med Sci. 10:204–209.
2010.PubMed/NCBI
|
|
18
|
Behar-Cohen FF, Thillaye-Goldenberg B, de
Bizemont T, Savoldelli M, Chauvaud D and de Kozak Y: EIU in the rat
promotes the potential of syngeneic retinal cells injected into the
vitreous cavity to induce PVR. Invest Ophthalmol Vis Sci.
41:3915–3924. 2000.PubMed/NCBI
|
|
19
|
No authors listed. The classification of
retinal detachment with proliferative vitreoretinopathy.
Ophthalmology. 90:121–125. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yanyali A and Bonnet M: Risk factors of
postoperative proliferative vitreoretinopathy in giant tears. J Fr
Ophtalmol. 19:175–180. 1996.(In French).
|
|
21
|
Jones JI and Clemmons DR: Insulin-like
growth factors and their binding proteins: biological actions.
Endocr Rev. 16:3–34. 1995.PubMed/NCBI
|
|
22
|
Burren CP, Berka JL, Edmondson SR, Werther
GA and Batch JA: Localization of mRNAs for insulin-like growth
factor-I (IGF-I), IGF-I receptor, and IGF binding proteins in rat
eye. Invest Ophthalmol Vis Sci. 37:1459–1468. 1996.PubMed/NCBI
|
|
23
|
Bergman PB, Moravski CJ, Edmondson SR, et
al: Expression of the IGF system in normal and diabetic transgenic
(mRen-2)27 rat eye. Invest Ophthalmol Vis Sci. 46:2708–2715. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gallicchio MA, Kaun C, Wojta J, Binder B
and Bach LA: Urokinase type plasminogen activator receptor is
involved in insulin-like growth factor-induced migration of
rhabdomyosarcoma cells in vitro. J Cell Physiol. 197:131–138. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gallicchio MA, Kneen M, Hall C, Scott AM
and Bach LA: Overexpression of insulin-like growth factor binding
protein-6 inhibits rhabdomyosarcoma growth in vivo. Int J Cancer.
94:645–651. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bach LA: Insulin-like growth factor
binding protein-6: the ‘forgotten’ binding protein? Horm Metab Res.
31:226–234. 1999.
|
|
27
|
Chaves J and Saif MW: IGF system in
cancer: from bench to clinic. Anticancer Drugs. 22:206–212. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kuo YS, Tang YB, Lu TY, Wu HC and Lin CT:
IGFBP-6 plays a role as an oncosuppressor gene in NPC pathogenesis
through regulating EGR-1 expression. J Pathol. 222:299–309. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Seurin D, Lassarre C, Bienvenu G and
Babajko S: Insulin-like growth factor binding protein-6 inhibits
neuroblastoma cell proliferation and tumour development. Eur J
Cancer. 38:2058–2065. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Leng SL, Leeding KS, Whitehead RH and Bach
LA: Insulin-like growth factor (IGF)-binding protein-6 inhibits
IGF-II-induced but not basal proliferation and adhesion of LIM 1215
colon cancer cells. Mol Cell Endocrinol. 174:121–127. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ricker LJ, Kijlstra A, Kessels AG, et al:
Interleukin and growth factor levels in subretinal fluid in
rhegmatogenous retinal detachment: a case-control study. PLoS One.
6:e191412011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pennock S and Kazlauskas A: Vascular
endothelial growth factor A competitively inhibits platelet-derived
growth factor (PDGF)-dependent activation of PDGF receptor and
subsequent signaling events and cellular responses. Mol Cell Biol.
32:1955–1966. 2012. View Article : Google Scholar
|
|
33
|
Ricker LJ, Dieudonné SC, Kessels AG, et
al: Antiangiogenic isoforms of vascular endothelial growth factor
predominate in subretinal fluid of patients with rhegmatogenous
retinal detachment and proliferative vitreoretinopathy. Retina.
32:54–59. 2012. View Article : Google Scholar
|
|
34
|
Liang CM, Tai MC, Chang YH, et al:
Glucosamine inhibits epithelial-to-mesenchymal transition and
migration of retinal pigment epithelium cells in culture and
morphologic changes in a mouse model of proliferative
vitreoretinopathy. Acta Ophthalmol. 89:e505–e514. 2011. View Article : Google Scholar
|
|
35
|
Karthikeyan B, Kalishwaralal K,
Sheikpranbabu S, Deepak V, Haribalaganesh R and Gurunathan S: Gold
nanoparticles downregulate VEGF-and IL-1β-induced cell
proliferation through Src kinase in retinal pigment epithelial
cells. Exp Eye Res. 91:769–778. 2010.PubMed/NCBI
|
|
36
|
Parrales A, López E and López-Colomé AM:
Thrombin activation of PI3K/PDK1/Akt signaling promotes cyclin D1
upregulation and RPE cell proliferation. Biochim Biophys Acta.
1813:1758–1766. 2011. View Article : Google Scholar : PubMed/NCBI
|
